Filing Analysis
Electromed, Inc. announced its financial results for the third quarter ended March 31, 2026, and provided an updated investor presentation. The disclosures were made via press release and are furnished as exhibits to the filing.
📋 Key Facts
- Announced Q3 FY2026 financial results for the period ended March 31, 2026.
- Updated the company's investor presentation for use in upcoming meetings with analysts and investors.
- Furnished press release as Exhibit 99.1 and investor presentation as Exhibit 99.2.
- The filing was made under Items 2.02 (Results of Operations) and 7.01 (Regulation FD Disclosure).
Electromed, Inc. filed an 8-K to announce its financial results for the second quarter ended December 31, 2025, and provided an updated investor presentation.
📋 Key Facts
- Report date: February 10, 2026
- Reporting period: Second quarter ended December 31, 2025
- The company issued a press release regarding financial results (Exhibit 99.1)
- The company updated its investor presentation for use in meetings with analysts and investors (Exhibit 99.2)
Electromed, Inc. entered into a $10 million senior secured revolving credit facility with BMO Bank N.A., maturing in December 2026. This agreement replaces an existing credit facility with Choice Financial Group and is intended to fund working capital and capital expenditures.
🚩 Red Flags
- The facility is secured by a first priority security interest in substantially all assets, increasing the risk for unsecured creditors.
- The inclusion of specific financial covenants (Fixed Charge Coverage and Debt/EBITDA) creates potential default risks if operational performance fluctuates.
📋 Key Facts
- Entered into a Credit Agreement with BMO Bank N.A. on December 16, 2025.
- The facility is a $10,000,000 senior secured revolving line of credit.
- Maturity date is set for December 16, 2026.
- Interest rate is one-month Term SOFR plus 1.75%, payable monthly.
- The facility is secured by a first priority security interest in substantially all existing and future assets.
- Financial covenants include maintaining a minimum Fixed Charge Coverage Ratio of at least 1.20x and Total Funded Debt to EBITDA ratio of not more than 2.50x.
Electromed, Inc. reported the results of its annual meeting of shareholders held on November 14, 2025. The filing details the election of eight directors and the ratification of the company's independent auditor.
📋 Key Facts
- Annual meeting held on November 14, 2025.
- Eight nominees designated by the Board were elected to the Board of Directors for one-year terms.
- Shareholders ratified the appointment of RSM US LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026.
- Shareholders approved executive compensation on a non-binding advisory basis (Say-on-Pay).
- Shareholders recommended that named executive officer compensation votes occur every year on an advisory basis.
Electromed, Inc. filed an 8-K to announce its financial results for the first quarter ended September 30, 2025 and to provide an updated investor presentation.
📋 Key Facts
- Reported date: November 12, 2025
- Period covered: First quarter ended September 30, 2025
- Included Exhibit 99.1: Press release regarding financial results
- Included Exhibit 99.2: Updated investor presentation
Electromed, Inc. announced that its board of directors has authorized a new share repurchase program. The company intends to repurchase up to $10.0 million of its outstanding common stock on the open market or through private transactions.
📋 Key Facts
- Board authorization for share repurchases issued on September 9, 2025.
- Maximum repurchase amount: $10.0 million.
- Repurchases to occur via open market and privately negotiated transactions.
- Timing and amount are subject to market conditions and corporate considerations.
Electromed, Inc. filed an 8-K to announce its financial results for the fourth quarter and fiscal year ended June 30, 2025. The filing also includes an updated investor presentation.
📋 Key Facts
- Report date: August 26, 2025
- Reporting period: Fourth quarter and fiscal year ended June 30, 2025
- Included Exhibit 99.1: Press release regarding financial results
- Included Exhibit 99.2: Updated investor presentation
Electromed, Inc. filed an 8-K to announce its financial results for the third quarter ended March 31, 2025 and provided an updated investor presentation.
📋 Key Facts
- Reported financial results for the fiscal third quarter ended March 31, 2025 via press release (Exhibit 99.1).
- Updated company investor presentation released on May 13, 2025 (Exhibit 99.2).
- Filed under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
Electromed, Inc. announced that its board of directors has authorized a new share repurchase program. The company intends to repurchase up to $5.0 million of its outstanding common stock on the open market or through private transactions.
📋 Key Facts
- Board authorization date: March 6, 2025
- Maximum repurchase amount: $5.0 million
- Method of repurchase: Open market and privately negotiated transactions
- Filing date: March 10, 2025
Electromed, Inc. filed an 8-K to announce its second quarter financial results for the period ended December 31, 2024 and updated its investor presentation.
📋 Key Facts
- Report date: February 11, 2025
- Reporting period: Second quarter ended December 31, 2024
- The company issued a press release regarding financial results (Exhibit 99.1)
- The company updated its investor presentation (Exhibit 99.2)
Electromed, Inc. filed an 8-K reporting the adoption of amended and restated bylaws containing non-substantive changes and the results of its annual shareholder meeting held on November 15, 2024.
📋 Key Facts
- The Board adopted Amended and Restated Bylaws to implement non-substantive/conforming changes, including gender-neutral pronoun designations.
- Eight directors were elected for one-year terms: James L. Cunniff, Stan K. Erickson, Gregory J. Fluet, Joseph L. Galatowitsch, Kathleen S. Skarvan, Andrew J. Summers, Kathleen A. Tune, and Andrea M. Walsh.
- Shareholders ratified the appointment of RSM US LLP as independent registered public accounting firm for fiscal year ending June 30, 2025.
- Shareholders approved executive compensation on a non-binding advisory basis (Say-on-Pay).
- The annual meeting was held on November 15, 2024.
Electromed, Inc. filed an 8-K to announce its financial results for the fiscal quarter ended September 30, 2024 and provided an updated investor presentation.
📋 Key Facts
- Report date: November 12, 2024
- Reporting period: Fiscal quarter ended September 30, 2024
- The filing includes a press release regarding financial results (Exhibit 99.1)
- The company updated its investor presentation for use in meetings with analysts and investors (Exhibit 99.2)
Electromed, Inc. announced that its board of directors has authorized a new share repurchase program. The company intends to repurchase up to $5.0 million of its outstanding common stock on the open market or through private transactions.
📋 Key Facts
- Board authorization for share repurchases issued on September 11, 2024.
- Maximum repurchase amount: $5.0 million.
- Repurchases will occur via open market or privately negotiated transactions.
- Timing and volume of repurchases are subject to market conditions.
Electromed, Inc. filed an 8-K to announce its financial results for the fiscal quarter and fiscal year ended June 30, 2024. The company also updated its investor presentation.
📋 Key Facts
- Announced financial results for the fiscal quarter and fiscal year ended June 30, 2024.
- Updated the Company's investor presentation (Exhibit 99.2).
- Filed on August 27, 2024.
Electromed, Inc. has issued an updated investor presentation and a corresponding press release to provide current information to investors and analysts.
📋 Key Facts
- The company updated its investor presentation on August 7, 2024.
- The update was released via a press release (Exhibit 99.2).
- The filing is made pursuant to Item 7.01 (Regulation FD Disclosure).
Electromed, Inc. filed an 8-K to announce its financial results for the fiscal quarter ended March 31, 2024 and updated its investor presentation.
📋 Key Facts
- Report date: May 7, 2024
- Reporting period: Fiscal quarter ended March 31, 2024
- The company issued a press release regarding financial results (Exhibit 99.1)
- The company updated its investor presentation (Exhibit 99.2)
Electromed, Inc. filed an 8-K to announce its financial results for the fiscal quarter ended December 31, 2023, and updated its investor presentation.
📋 Key Facts
- Report date: February 13, 2024
- Reporting period: Fiscal quarter ended December 31, 2023
- Company issued a press release regarding financial results (Exhibit 99.1)
- Company updated its investor presentation for use in meetings with investors and analysts (Exhibit 99.2)